Recon: Siemens Healthineers seeks takeover of Novartis’ molecular imaging business; FDA expands probe into Lykos MDMA drug studies
ReconJason Scott
EuropeGCPGlobalNorth AmericaRegulatory Intelligence/PolicyUnited StatesReconJason ScottEuropeGCPGlobalNorth AmericaRegulatory Intelligence/PolicyUnited States